In recent years, safety recalls have occurred frequently in the biopharmaceutical industry, which affects the health of consumers. This article attempts to use the fsQCA method to draw a conclusion through the study of ESG and its quantification system, as well as the study of data samples related to MES and GMP processes, that is, MES-DPT has a positive impact on process safety management, and GMP-DPT has a positive impact on process safety. Management has a positive and positive impact, and ESG-DPT has a positive and positive impact on process safety management. Finally, this article puts forward suggestions for improving ESG-DPT, MES-DPT, GMP-DPT and the biomedical ESG-DPT model. Future research hopes to further study ESG -DPT model and ESG biomedical industry indicators.

Ⅰ. Introduction
Ⅱ. Theoretical Background
    1. Introduction to ESG MES GMP and DPT Concepts
    2. ESG quantificatiON SYSTEM and Production Theory
    3. Aspects of the Existing Evaluation System that Need to Be Improved (ProblemsRaised)
Ⅲ. Research Methods
    1. fsQCA Data Analysis Method
    2. Collection and Analysis of Biopharmaceutical Companies such as Celltrion andRelated Data
Ⅳ. Research Results
    1. Model
    2. Hypothesis
    3. Analysis Results
Ⅴ. Conclusion and Prospects
    1 Proposal of DPT model
    2. Conclusion
    3. Limitation and Future Research

• Gao Yu(Associate Professor, Shanxi University of Chinese Medicine, China)
• Wang Lingyan(Ph.D., Department of Global Food Service Management, Woosuk University) Corresponding Author
• Qin Bingbing(Doctoral Student, Department of Social Economy, Business Adminstration, Woosuk University)